US › Healthcare

SeaStar Medical Holding Corporation (ICU)

US · Healthcare · Biotechnology

$3.50+13.55%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$615,000

Revenue YoY

+82.0%

Net profit

$-3.7M

EPS

$-0.91

EPS estimate

$-0.91

Net margin

-606.5%

EPS came in at -0.91 against a street estimate of -0.91 — a beat of 0.0%.

Key statistics

Market cap

$13.3M

Forward P/E

0.0

P/B

3.15

Book value

$1.01

EPS (TTM)

$-1.89

52-week high

$12.50

52-week low

$2.07

50-day MA

$3.56

200-day MA

$3.26

Beta

-1.03

Analyst view

Analysts rate SeaStar Medical Holding Corporation a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $10.00.

Shareholding

Insiders

11.62%

Institutions

7.62%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	1.26%
Vanguard Capital Management, LLC	0.65%
Jane Street Group LLC	0.63%
Vanguard Fiduciary Trust Co	0.31%
PNC Financial Services Group Inc	0.04%
Tower Research Capital LLC	0.03%
BlackRock Inc	0.02%
UBS Group AG	0.02%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for SeaStar Medical Holding Corporation — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.